The National Center for Genome Resources (NCGR) announced today that it has broken the 20 billion DNA sequence barrier for the first time with an Illumina Genome Analyzer. Using a single Illumina flowcell, NCGR scientists generated more than 20 billion bases (or letters) of high quality human DNA sequence – seven-times the length of a […]
GenoLogics today announced that Wellcome Trust is deploying its lab and data management solution for genomics, including integrations to next generation sequencing platforms. The Wellcome Trust Centre for Human Genetics (WTCHG) undertakes research into the genetic basis of multi-factorial diseases such as hypertension, diabetes, heart disease, infectious diseases, psychiatric disorders and multiple sclerosis. The Genomics […]
Illumina (NASDAQ:ILMN) today announced that researchers at Duke University Medical Center will utilize Illumina’s Genome Analyzer to study the resistance to HIV infection among 50 individuals that were highly exposed to the virus, but who remain uninfected. Duke University researchers will sequence the complete genome of at least 50 individuals with the desired phenotype. David […]
Illumina (NASDAQ:ILMN) and Oxford Nanopore Technologies (“Oxford Nanopore”) today announced a strategic alliance including a commercialization agreement and equity investment. Under the terms of the commercialization agreement, Illumina will exclusively market, sell, distribute, and service BASE™ Technology products developed by Oxford Nanopore for DNA sequencing into the research and diagnostic markets on a worldwide basis. […]
Illumina (NASDAQ: ILMN) today announced that researchers at the Beijing Genomics Institute (BGI), Shenzhen are the first to complete de novo sequencing of the giant panda genome. Exclusively using Illumina’s Genome Analyzer, a small team of scientists—in one month—produced 150 gigabases of sequence that was used to assemble the three gigabase genome belonging to Jingiing, […]
Illumina, Inc. (NASDAQ:ILMN) announced today that it has introduced the Illumina CSProTM Program for Sequencing. This new extension to the program allows organizations with the Illumina Genome Analyzer to become certified in order to provide a range of sequencing-based genetic analysis services. The Illumina CSPro Program is the only program of its kind to offer […]
Expression Analysis, Inc., a leading provider of genomic services for clinical trials and research, has entered the Agricultural market and will debut its new services at the upcoming International Plant & Animal Genome Conference in San Diego next week. This announcement comes on the heels of the recent purchase of an Illumina Genome Analyzer. “We […]
Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain investors to raise approximately $18.6 million in gross proceeds in a private placement through the sale of shares of its […]
454 Life Sciences, a Roche company, announced today that a team of researchers from the BC Centre of Excellence in HIV/AIDS and the University of British Columbia, Canada have used the Genome Sequencer FLX system to monitor low frequency HIV variants from human samples in a recent study. The preliminarily results of the study were […]
Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the introduction of two reagent solutions to simplify genomic and transcriptome analysis on next-generation, high-throughput genomic analysis platforms. Both solutions provide basic and clinical researchers with an innovative workflow that greatly reduces the time, cost, and experimental variability […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
